ALVR AlloVir


Data from SEC filings
Employee count

ESG framework mentions

In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM
The Company held its Annual Meeting of Stockholders (the “Annual Meeting”) on May 25, 2021. As of March 29, 2021, the record date for the Annual Meeting, there were 65,106,873 shares of the Company’s common stock outstanding and entitled to vote at the Annual Meeting. The Company’s stockholders voted on the following matters, which are described in detail in the Company’s Definitive Proxy Statement filed with the U.S. Securities and Exchange Commission on April 12, 2021: (i) to elect each of Juan Vera, M.D., Ansbert Gadicke, M.D., and Morana Jovan-Embiricos, Ph.D as a Class I member of the board of directors, to serve until the Company’s 2024 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified (“Proposal 1”) and (ii) to ratify the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021 (“Proposal 2”).

The Company’s stockholders approved the Class I director nominees recommended for election in Proposal 1 at the Annual Meeting. The Company’s stockholders voted for the Class I directors as follows:

Class I Director NomineeForWithholdBroker
Juan Vera, M.D.55,146,6642,791,8603,615,172
Ansbert Gadicke, M.D.53,984,9613,953,5633,615,172
Morana Jovan-Embiricos, Ph.D56,212,5651,725,9593,615,172

The Company’s stockholders approved Proposal 2. The votes cast at the Annual Meeting were as follows:


No other matters were submitted to or voted on by the Company’s stockholders at the Annual Meeting.